Adult Hepatocellular Carcinoma Completed Phase 2 Trials for Temsirolimus (DB06287)

Also known as: Hepatocellular Carcinoma, Adult / Adult hepatocellular carcinoma (disorder)

IndicationStatusPhase
DBCOND0040123 (Adult Hepatocellular Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01010126Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerTreatment